Sharon Bligh, director of Health & Wellness at The Consumer Goods Forum, explains how FMCGs are going beyond cutting sugar to collaborating with local authorities to promote health and wellness.
With cancer and diabetes now more prevalent in poor countries than in the West, 23 companies, including Pfizer, Novartis, GlaxoSmithKline and Japan's Takeda, are developing partnerships in some of the hardest-hit regions to extend access to life-saving medicines